Background: Low back pain (LBP) is the 5th leading cause of physician consultation and is a significant cause of lost workforce hours with tremendous economic implications in every society. These findings suggest that medical practice in Nigeria is a potential risk factor for developing low back pain. Few studies have attempted to evaluate the medical specialties as risk factors for LBP. This study evaluates the prevalence of low back pain among various Specialist Medical Consultants in a typical Teaching Hospital. Methodology: This is a descriptive cross-sectional study performed using self-administered questionnaires. The study population comprised Specialist Medical Consultants working at the University of Port Harcourt Teaching Hospital, Port Harcourt, Rivers State. The questionnaires were distributed among consultant physicians regardless of their departments. Information about their age, sex, medical specialties, presence frequency and severity of LBP; interventions received, and outcome were obtained. Result: There were 98 respondents, 56 (57%) males and 42 (43%) females who participated in the study. The modal age of the respondents is the 41-50 years age group (45%). 44%, were from the surgical specialties (surgery, anaesthesia, oral and maxillofacial surgery, ophthalmology); 33% from the internal and family medicine specialties; (11) 11% pediatricians and (12) 12.2 % were pathologists. The prevalence of low back pain was 60.2%, slightly more prevalent in males (62%) than females (58%). Of those who have experienced low back pain, 35.6% suffered mild pain (VAS 1-4), 49% suffered moderate pain (VAS 5-7) while 17% suffered severe pain (VAS 8-10). The majority (57.6%) had suffered more than 3 episodes of LBP while 84.8% sought treatment for their symptom mostly using NSAIDS. Conclusion: LBP has a high prevalence among Specialist Medical Consultants in UPTH potentially affecting patient treatment and student education. Most consultants take NSAIDS as treatment for low back pain.

該數(shù)據(jù)集名為Diabetes，是一個(gè)英文單語種數(shù)據(jù)集，包含1K到10K的數(shù)據(jù)量。數(shù)據(jù)來源于原始收集，主要用于文本分類任務(wù)。

該數(shù)據(jù)集包含音頻、文件路徑、指令和標(biāo)簽四個(gè)特征。數(shù)據(jù)集主要分為測試集，共有174個(gè)樣本，總數(shù)據(jù)量約為439215133字節(jié)，下載所需空間約為417638360字節(jié)。測試數(shù)據(jù)文件存儲路徑為data/test-*。

This source appears in the European Health for All Database.

This source appears in the European Health for All Database.

This source appears in the European Health for All Database and the European Hospital Morbidity Database.

This source appears in the European Health for All Database.

新北市婚後孕前健康檢查機(jī)構(gòu)相關(guān)資訊(新北市永和區(qū)中興街80號)

This source appears in the European Health for All Database.

This dataset contains inpatient hospital discharge information as reported to the National Institute of Statistics and Censuses (INEC) in Ecuador. INEC collects these data on a monthly basis, from hospitals in both the public and private sectors.

該數(shù)據(jù)集包含一個(gè)名為text的字符串類型特征，分為一個(gè)訓(xùn)練集，包含1000個(gè)樣本，總字節(jié)數(shù)為2979647。數(shù)據(jù)集的配置名為default，數(shù)據(jù)文件路徑為data/train-*。

**Overview** This data package contains datasets that have been used to build the Drugs@FDA. The information is classified by health information, regulatory information and advanced search. This data package contains the necessary technical information (excluding programming scripts) to reproduce the online version of Drugs@FDA. The data package is best to use with a database program. **Description** Drugs at FDA is a database of FDA Approved Drug Products available in the FDA official website for search by drug name, active ingredient or application number. It provides information of drug (generic) name, active ingredient, form and strength available, FDA application number, label info, dosage form or route, marketing status and pharmaceutical company as well as patient information, approval letters, review and other facts for drugs approved after 1997. Drugs@FDA contains prescription and over-the-counter human drugs and therapeutic biologicals currently approved for sale in the United States. Drugs@FDA includes discontinued drugs and "Chemical Type 6" approvals. Drugs@FDA contains the following therapeutic biological products: - monoclonal antibodies - cytokines, growth factors, enzymes, immunomodulators; and thrombolytics - proteins intended for therapeutic use that are extracted from animals or microorganisms, including recombinant versions of these products (except clotting factors) - other non-vaccine therapeutic immunotherapies **Benefits** - The data package is useful for finding labels for approved drug products, generic drug products for an innovator drug product, therapeutically equivalent drug products for an innovator or generic drug product, consumer information for drugs, all drugs with a specific active ingredient, viewing the approval history of a drug. **License Information** The use of John Snow Labs datasets is free for personal and research purposes. For commercial use please subscribe to the [Data Library](https://www.johnsnowlabs.com/marketplace/) on John Snow Labs website. The subscription will allow you to use all John Snow Labs datasets and data packages for commercial purposes. **Included Datasets** - [Approved Risk Evaluation and Mitigation Strategies Materials Data](https://johnsnowlabs.com/wp-json/datasets-api/v1/approved-risk-evaluation-and-mitigation-strategies-materials-data)- The Approved Risk Evaluation and Mitigation Strategies Materials (REMS) dataset includes data on all of the materials that have ever been part of a REMS program, including information on materials that are no longer subject to a Risk Evaluation and Mitigation Strategies (REMS). - [Approved Risk Evaluation and Mitigation Strategies Products Data](https://johnsnowlabs.com/wp-json/datasets-api/v1/approved-risk-evaluation-and-mitigation-strategies-products-data)- The Approved Risk Evaluation and Mitigation Strategies Products dataset includes data on all of the drugs that have ever been part of a REMS program, including information on products that are no longer marketed and/or no longer subject to a Risk Evaluation and Mitigation Strategies (REMS). - [Clinical Investigator Inspection List](https://johnsnowlabs.com/wp-json/datasets-api/v1/clinical-investigator-inspection-list)- The Clinical Investigator Inspection List (CLIIL) contains names, addresses, and other pertinent information gathered from inspections of clinical investigators who have performed studies with investigational new drugs. - [Clinical Investigators Disqualification Proceedings](https://johnsnowlabs.com/wp-json/datasets-api/v1/clinical-investigators-disqualification-proceedings)- The Clinical Investigators Disqualification Proceedings dataset lists clinical investigators who are or have been subject to an administrative clinical investigator disqualification action and indicates the current status of that action. - [Drugs Application Number and Sponsor](https://johnsnowlabs.com/wp-json/datasets-api/v1/drugs-application-number-and-sponsor)- This dataset contains the Applications part to build the Drugs@FDA database. Drugs at FDA is a database of FDA Approved Drug Products available on the FDA official website. It provides information of drug (generic) name, active ingredient, form and strength available, FDA application number, label info, dosage form or route, marketing status and pharmaceutical company as well as patient information, approval letters, review and other facts for drugs approved after 1997. - [Drugs Application Submission Property Type](https://johnsnowlabs.com/wp-json/datasets-api/v1/drugs-application-submission-property-type)- This dataset contains the Application Submission Property Type part to build the Drugs@FDA database. Drugs at FDA is a database of FDA Approved Drug Products available on the FDA official website. It provides information of drug (generic) name, active ingredient, form and strength available, FDA application number, label info, dosage form or route, marketing status and pharmaceutical company as well as patient information, approval letters, review and other facts for drugs approved after 1997. - [Drugs Data File Document Addresses](https://johnsnowlabs.com/wp-json/datasets-api/v1/drugs-data-file-document-addresses)- This dataset contains the Application Documents part to build the Drugs@FDA database. Application Documents refers to "document addresses or URLs to letters, labels, reviews, Consumer Information Sheets, FDA Talk Papers, and other types. Drugs at FDA provides information of drug name, active ingredient, strength, application number, label info, dosage form or route, marketing status as well as patient information, approval letters, review and other facts for drugs approved after 1997. - [Drugs Database Marketing Status](https://johnsnowlabs.com/wp-json/datasets-api/v1/drugs-database-marketing-status)- This dataset contains the Marketing Status part to build the Drugs@FDA database. Drugs at FDA is a database that provides information of drug (generic) name, active ingredient, form and strength available, FDA application number, label info, dosage form or route, marketing status and pharmaceutical company as well as patient information, approval letters, review and other facts for drugs approved after 1997. - [Drugs Database Products Included](https://johnsnowlabs.com/wp-json/datasets-api/v1/drugs-database-products-included)- This dataset contains the Product part to build the Drugs@FDA database. Drugs at FDA is a database of FDA Approved Drug Products available on the FDA official website. It provides information of drug (generic) name, active ingredient, form and strength available, FDA application number, label info, dosage form or route, marketing status and pharmaceutical company as well as patient information, approval letters, review and other facts for drugs approved after 1997. - [Drugs Database Submissions Included](https://johnsnowlabs.com/wp-json/datasets-api/v1/drugs-database-submissions-included)- This dataset contains the Application Submission part to build the Drugs@FDA database from the Food and Drug Administration (FDA) Approved Drug Products available on their official website. It provides information on drug (generic) name, active ingredient, form and strength available, FDA application number, label info, dosage form or route, marketing status, and pharmaceutical company as well as patient information, approval letters, review and other facts for drugs approved after 1997. - [Drugs Therapeutic Equivalence Code](https://johnsnowlabs.com/wp-json/datasets-api/v1/drugs-therapeutic-equivalence-code)- This dataset contains the Therapeutic Equivalence Code part to build the Drugs@FDA database. Application Documents refers to "document addresses or URLs to letters, labels, reviews, Consumer Information Sheets, FDA Talk Papers, and other types. Drugs at FDA is a database of FDA Approved Drug Products. It provides information of drug (generic) name, active ingredient, form and strength available, FDA application number, label info, dosage form or route, marketing status and other facts. - [FDA Drug Discontinuation](https://johnsnowlabs.com/wp-json/datasets-api/v1/fda-drug-discontinuation)- The Food and Drug Administration (FDA) Drug discontinuation database includes information about current drugs in discontinuations of specific drug products, resource information, and relevant links. - [FDA Drug Master Files Directory](https://johnsnowlabs.com/wp-json/datasets-api/v1/fda-drug-master-files-directory)- This dataset contains a list of the Drug Master Files (DMF) submitted to the Food and Drug Administration (FDA) and the Center for Drug Evaluation and Research (CDER) since 1900 to the current date. Drug Master Files are submitted by pharmaceuticals (holders) to the CDER providing confidential information on facilities, processes and articles implemented in the production of human drugs. - [FDA Drug Shortages](https://johnsnowlabs.com/wp-json/datasets-api/v1/fda-drug-shortages)- Food and Drug Administration (FDA) Drug Shortages includes information about current drugs in shortage and resolved shortages of specific drug products, resource information, and relevant links. - [FDA Inspections Database](https://johnsnowlabs.com/wp-json/datasets-api/v1/fda-inspections-database)- The Food and Drug Administration (FDA) conducts careful inspections of regulated facilities to determine a firm's compliance with regulations and the Food, Drug and Cosmetic Act. **Data Engineering Overview** **We deliver high-quality data** - Each dataset goes through 3 levels of quality review - 2 Manual reviews are done by domain experts - Then, an automated set of 60+ validations enforces every datum matches metadata & defined constraints - Data is normalized into one unified type system - All dates, unites, codes, currencies look the same - All null values are normalized to the same value - All dataset and field names are SQL and Hive compliant - Data and Metadata - Data is available in both CSV and Apache Parquet format, optimized for high read performance on distributed Hadoop, Spark & MPP clusters - Metadata is provided in the open Frictionless Data standard, and its every field is normalized & validated - Data Updates - Data updates support replace-on-update: outdated foreign keys are deprecated, not deleted **Our data is curated and enriched by domain experts** Each dataset is manually curated by our team of doctors, pharmacists, public health & medical billing experts: - Field names, descriptions, and normalized values are chosen by people who actually understand their meaning - Healthcare & life science experts add categories, search keywords, descriptions and more to each dataset - Both manual and automated data enrichment supported for clinical codes, providers, drugs, and geo-locations - The data is always kept up to date – even when the source requires manual effort to get updates - Support for data subscribers is provided directly by the domain experts who curated the data sets - Every data source’s license is manually verified to allow for royalty-free commercial use and redistribution. **Need Help?** If you have questions about our products, contact us at [info@johnsnowlabs.com](mailto:info@johnsnowlabs.com).

This source appears in the European Health for All Database.

This source appears in the European Health for All Database and the European Hospital Morbidity Database.

This source appears in the European Health for All Database.

This source appears in the European Health for All Database.

This source appears in the European Health for All Database.

This dataset contains inpatient hospital discharge information as reported to the National Institute of Statistics and Censuses (INEC) in Ecuador. INEC collects these data on a monthly basis, from hospitals in both the public and private sectors.

These data are reported in the European Renal Association - European Dialysis and Transplant Association Registry Annual Report 2010.

--- dataset_info: features: - name: q dtype: string - name: i dtype: string - name: a dtype: string - name: filename dtype: string - name: context dtype: string - name: count dtype: int64 - name: text dtype: string - name: text1 dtype: string splits: - name: train num_bytes: 196338950 num_examples: 21281 download_size: 19781209 dataset_size: 196338950 configs: - config_name: default data_files: - split: train path: data/train-* ---

相關(guān)知識

華為發(fā)布醫(yī)技數(shù)字化2.0解決方案，AI助力精準(zhǔn)醫(yī)療
數(shù)字醫(yī)療解決方案：五步行動指南
數(shù)字孿生：個(gè)性化精準(zhǔn)醫(yī)療的解決方案和應(yīng)用場景
數(shù)字醫(yī)療解決方案和移動醫(yī)療正在推進(jìn)制藥及醫(yī)療保健行業(yè)發(fā)展
平安萬家醫(yī)療云平臺喜獲“2017最I(lǐng)N數(shù)字醫(yī)療解決方案”十強(qiáng)稱號
RIIL醫(yī)療信息化運(yùn)營解決方案——基于數(shù)字化醫(yī)療，構(gòu)筑信息化運(yùn)營
2019年醫(yī)療行業(yè)信息化解決方案.ppt
醫(yī)療健康業(yè)IT解決方案
智慧醫(yī)療健康解決方案
航天正陽數(shù)字健康城市解決方案

網(wǎng)址: 醫(yī)療數(shù)字化解決方案 http://m.u1s5d6.cn/newsview891597.html